A Multicenter, Open-label, Prospective Study to Evaluate Antiviral Efficacy and Safety of Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

Trial Profile

A Multicenter, Open-label, Prospective Study to Evaluate Antiviral Efficacy and Safety of Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Nov 2014

At a glance

  • Drugs Entecavir (Primary) ; Tenofovir
  • Indications Hepatitis B
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 30 Jan 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 30 Jan 2014 Planned End Date changed from 1 May 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
    • 15 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top